Tempest Therapeutics Inc.

NASDAQ: TPST · Real-Time Price · USD
10.58
1.10 (11.60%)
At close: Aug 15, 2025, 3:59 PM
10.72
1.32%
After-hours: Aug 15, 2025, 07:28 PM EDT

Tempest Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 486K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
67K 68K 243K 98K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-67K -68K 243K -98K n/a n/a -85K -510K -497K -557K -539K -442K -414K -419K -409K -422K -217K -176K
Operating Income
-7.97M -10.94M -13.92M -10.55M -9.58M -7.97M -7.51M -6.59M -7.47M -7.58M -8.93M -8.77M -8.77M -8.16M -7.34M -7.74M -6.79M -5.13M
Interest Income
142K 237K 352K 324K 384K 438K 388K n/a 244K 289K 326K n/a 70K 3K n/a 63K 3K 3K
Pretax Income
-7.87M -10.86M -13.81M -10.56M -9.57M -7.9M -7.49M -6.79M -7.58M -7.64M -9.1M -8.95M -9.17M -8.49M -7.78M -8.11M -7.06M -5.36M
Net Income
-7.87M -10.86M -13.81M -10.56M -9.57M -7.9M -7.49M -6.79M -7.58M -7.64M -9.1M -9.12M -9.17M -8.49M -7.78M -8.11M -7.06M -5.36M
Selling & General & Admin
4.09M 3.31M 3.18M 2.99M 3.75M 3.63M 3.33M 2.37M 3.05M 2.9M 3.14M 2.8M 3.12M 3.05M 2.62M 3.11M 2.56M 1.53M
Research & Development
3.87M 7.63M 10.74M 7.56M 5.84M 4.34M 4.18M 4.22M 4.42M 4.68M 5.79M 5.97M 5.65M 5.11M 4.71M 4.63M 4.23M 3.59M
Other Expenses
-67K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
7.9M 10.94M 13.92M 10.55M 9.58M 7.89M 7.51M 6.59M 7.47M 7.58M 8.93M 8.77M 8.77M 8.16M 7.34M 7.74M 6.79M 5.13M
Interest Expense
46K 161K 247K 329K 372K 368K 377K 373K 355K 344K 432K 389K 464K 333K 441K 437K 276K 231K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.97M 10.94M 13.92M 10.55M 9.58M 7.97M 7.51M 6.59M 7.47M 7.58M 8.93M 8.77M 8.77M 8.16M 7.34M 7.74M 6.79M 5.13M
Income Tax Expense
n/a n/a n/a n/a n/a 44.72K n/a n/a n/a n/a n/a 176K n/a n/a n/a 63K 3K n/a
Shares Outstanding (Basic)
3.8M 3.44M 27.9M 25.81M 22.55M 22.23M 21.52M 14.12M 14.1M 13.76M 10.52M 13.64M 11.57M 7.17M 6.72M 6.72M 925.43K 6.64M
Shares Outstanding (Diluted)
3.8M 3.44M 27.9M 25.81M 22.55M 22.23M 21.52M 14.12M 14.1M 13.76M 10.52M 13.64M 11.57M 7.17M 6.72M 6.72M 925.43K 6.64M
EPS (Basic)
-2.07 -3.16 -0.5 -0.41 -0.42 -0.36 -0.35 -0.48 -0.54 -0.58 -0.95 -0.66 -0.79 -1.18 -1.16 -1.21 -7.63 -0.81
EPS (Diluted)
-2.07 -3.16 -0.5 -0.41 -0.42 -0.36 -0.35 -0.48 -0.54 -0.58 -0.95 -0.66 -0.79 -1.18 -1.16 -1.21 -7.63 -0.81
EBITDA
-7.97M -10.63M -13.52M -10.13M -9.04M -7.45M -7.03M -5.9M -6.73M -6.74M -8.13M -8.12M -8.29M -8.05M -7.24M -7.25M -6.57M -5.05M
EBIT
-7.82M -10.7M -13.57M -10.23M -9.2M -7.54M -7.11M -6.41M -7.23M -7.29M -8.67M -8.56M -8.7M -8.16M -7.44M -7.67M -6.78M -5.13M
Depreciation & Amortization
67K 68K 49K 97K 155K 88K 85K 510K 497K 557K 539K 442K 414K 108K 102K 422K 217K 176K